Tadagra-20 RSM Enterprises

£28.00

Tadagra-20 from RSM Enterprises contains tadalafil citrate (20mg) for erectile dysfunction research. Laboratory-grade compound for in-vitro studies examining PDE5 inhibition mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Tadagra-20 RSM Enterprises
Tadagra-20 RSM Enterprises
£28.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Tadagra-20 RSM Enterprises at a Glance

Tadagra-20 is a tadalafil citrate formulation manufactured by RSM Enterprises, containing 20mg of the active pharmaceutical ingredient per tablet. Tadalafil citrate is a potent phosphodiesterase type 5 (PDE5) inhibitor extensively studied in cardiovascular and urological research applications. This research-grade compound enables investigators to examine PDE5 enzyme inhibition pathways, cyclic guanosine monophosphate (cGMP) regulation, and smooth muscle relaxation mechanisms in controlled laboratory environments. As part of our comprehensive research chemical portfolio at Stroid UK Shop, Tadagra-20 provides researchers with pharmaceutical-grade materials for advancing understanding of nitric oxide signalling pathways.

Research Applications

Tadalafil citrate research focuses primarily on its selective inhibition of PDE5 enzymes, which play crucial roles in smooth muscle function and vascular biology. Laboratory studies investigate how PDE5 inhibition affects cGMP degradation, leading to enhanced nitric oxide-mediated smooth muscle relaxation in vascular tissues. Researchers examine tadalafil’s molecular interactions with PDE5 active sites, comparing binding affinities and selectivity profiles against other phosphodiesterase enzymes. Additionally, investigators study the compound’s pharmacokinetic properties, including its extended half-life compared to other PDE5 inhibitors. Our erection drugs category supports comprehensive studies in this important therapeutic area. Cardiovascular research applications include examining tadalafil’s effects on pulmonary arterial pressure, endothelial function, and exercise capacity in experimental models. Researchers also investigate potential neuroprotective mechanisms and cellular signalling cascades influenced by PDE5 modulation, expanding beyond traditional vascular applications to explore broader therapeutic potential in various disease models.

Specifications

Tadagra-20 Research Specifications
Parameter Value
Active Ingredient Tadalafil Citrate
Strength 20mg per tablet
Manufacturer RSM Enterprises
CAS Number 171596-29-5
Molecular Formula C₂₂H₁₉N₃O₄
Molecular Weight 389.40 g/mol
Storage Room temperature, dry conditions

Each tablet provides precisely measured tadalafil citrate content suitable for quantitative research applications. Our quality assurance processes ensure consistent potency and purity for reliable experimental results across SARMS and other research categories.

Compliance Statement

Tadagra-20 is manufactured exclusively for in-vitro laboratory research and scientific investigation purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must possess appropriate qualifications and laboratory facilities for safe compound handling. All studies should comply with institutional research protocols and safety guidelines. Storage and disposal must follow hazardous material regulations applicable to pharmaceutical research compounds. Similar compliance standards apply across our peptides and related research product categories. Purchase is restricted to qualified research institutions and licensed investigators only.

Related